Blood and Marrow Transplant (BMT) nurses must posses a vast knowledge of many complicated nursing assessment skills. Supportive measures that the team must institute to carry a patient safely through this treatment regimen, include administration of broad-spectrum antibiotics and blood products. Of the many responsibilities for BMT nurses blood administration is a major psychomotor skill that is performed daily and often perceived as an easy skill when in actuality it can be a very involved process. BMT patients need a variety of blood products, including PRBC, platelets, cryoprecipitate, fresh frozen plasma, and WBC's for different reasons and the BMT nurse must be aware of these products and indications to use them. It is important that nurses are aware of compatibility issues, leukocyte reduced products, irriated products, indications for use of specific products as well as possible patient responses to these products. It is also crucial to know the implication for BMT patients, especially in the allogeneic patients when blood type between patient and donor may not be compatible.
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Reviewing ABO and Rh compatibility information serves as a basis for understanding the procedures and assessment that are critical for a safe and successful transfusion. BMT patients have the added complication of changing blood types and the BMT nurse must be aware of this time period to deliver the safest product. Items to be reviewed include ABO and RH typing, ABO compatibility, signs and symptoms of transfusion reaction as well as delayed reaction, irradiation, leukocyte reduction, donor issues, implications of transfusion for BMT patients, and nursing care and assessment of transfusions. An article with CEU credit will also be distributed.
Most often the care of a patient receiving a transfusion is routine and uneventful. However, a great deal of knowledge is required before a nurse can understand aspects of transfusion therapy and intervene when a reaction does occur. Consistent high level nursing assessment and skills are paramount to knowing how and when to intervene.
NURSING MANAGEMENT OF PATIENT WITH HEMORRHAGIC CYSTITIS POST BMT Dela Cruz, B.P. MD Anderson Cancer Center, Houston, TX
Hemorrhagic cystitis is a syndrome of hematuria with symptoms of urinary tract irritability indicated by dysuria, frequency and urgency. Incidence varies according to conditioning regimen, preventative measures employed, and graft versus host disease prophylaxis used. There are two types of occurrences: 1. Early onset happens during or shortly after the conditioning regimen in which patients may have received cyclophosphamide, ifosphamide or busulfan. 2. Late onset occurs weeks to months after bone marrow transplant related to contraction of certain viruses. BMT patient who are immunocompromised, viruses are reactivated and excreted in the urine. In general viral shredding occurs 2-8 weeks after BMT and resolves spontaneously within three weeks. Another risk factor that contributes to hemorrhagic cystitis is GVHD. The bladder epithelium is a target organ for GVHD to attack and immunosuppressed patients already having associated complications with GVHD have an increased risk for acquiring viral infections.
Standard treatment modalities of hemorrhagic cystitis are: 1. Hydrating patients with intravenous and oral fluids. 2. Continuous bladder irrigation. 3. Bladder Instillation with Alum, Carboprost, silver nitrate, phenol, prostaglandin, and hydrocortisone. 4. Giving smooth muscle relaxants for bladder spasms. 5. Antiviral therapy. 6. Cystoscopy. 7. Our center is studying NOVO-seven injections to help with the clotting mechanism.
The nurses have an essential role in early detection. Mnemonics that would assist nurses in patient assessment is "U PAAS BI." U-urinary output, P-pain management, A-assessment of urine, S-specimen collection for urine cytology, B-blood counts and I-infusion of blood products as necessary. Chemotherapy and viruses may account for a substantial proportion of late onset and long lasting hemorrhagic cystitis in BMT patients. In conclusion, nursing plays a huge role in prevention, early detection and treatment of hemorrhagic cystitis.
THERAPEUTIC MILESTONE OF DONOR LYMPHOCYTE INFUSION
Austria, M.L.R., Ramirez, M.P.T. MD Anderson Cancer Center, Houston, TX Since early 1990, several studies cited that transfusion of donor lymphocytes is effective in inducing remission in patients with relapsed hematologic malignancies after allogeneic stem cell transplant. The procedure requires the leukocyte donor, which in most cases is the original donor to undergo leukopheresis. The lymphocytes are then infused into the patient either immediately or after it has been frozen. Such treatment attempts the donor's lymphocytes to seek out the patient's cancer cells and eventually destroy them without the need for further high-dose chemotherapy or second transplant. This beneficial effect is called graft-versusmalignancy effect.
Donor lymphocyte infusion (DLI) is used for various malignancies. The majority of Chronic Myelogenous Leukemia (CML) patients have impressive outcomes but less effective in acute leukemias, myelodysplasia, multiple myeloma, Hodgkin's disease, and non-Hodgkin's lymphoma. In addition, the presence of chronic graft-versus-host disease (GVHD) after initial bone marrow transplant, T-cell depletion, underlying disease and stage at relapse, and the level of mixed chimerism influence the response rate. It works effectively at the stage of minimum residual disease (MRD) and should be used at the first signs of disease recurrence (Sladen, S.). The main causes of morbidity and treatment-related toxicities include GVHD and bone marrow aplasia, with increased immunosuppression and susceptibility to opportunistic infections.
Continued research is ongoing to determine the long-term effectiveness of DLI, minimizing its side effects and the induction of graft versus malignancy effect.
Response rate of various malignancies from DLI and a case study will be presented. Kruse, S.M., Schmit-Pokorny, K. University of Nebraska Medical Center, Omaha, NE Development of a professional patient education tool that provides consistent education but is easy to update has been difficult for blood and marrow stem cell transplantation (BMSCT). Many videos exist that have been developed at a high cost. However, videos out-date very quickly and it is impossible to ensure each patient has the most current copy of the information.
DEVELOPMENT OF A TRANSPLANT EDUCATIONAL PROGRAM THAT PROVIDES CONSISTANT EDUCATION, IS AVAILABLE ON-DEMAND, AND IS EASY TO UPDATE
For many years at our transplant center, the initial educational session was 1:1 with the patient and family. The sessions provided information on the basics of BMSCT and lasted 2-3 hours. Due to duplication of nursing effort and lack of consistent information, a class for BMSCT was developed in 1995. The nurse case managers would rotate teaching the class that consisted of a slide show presentation and an outline. There were variations and inconsistencies in the information given depending on the nurses' area of expertise and their teaching abilities.
In 2003, a 40-minute multimedia presentation, consisting of scripted audio specific to each corresponding visual media, and streaming video was developed. This presentation is available to patients and family on a 'video on-demand service' available in all transplant patient suites, treatment center rooms, and other patient care areas. The patient or caregiver can view the presentation 24 hours a day at their convenience. Over a period of seven months,
